Phio Pharmaceuticals Corp.
PHIO • NASDAQ
Phio Pharmaceuticals Corp. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert J. Bitterman, with a market cap of $14.5M.
Market Cap$14.5M
Employees9.0
CEORobert J. Bitterman
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Phio Pharmaceuticals Corp. FAQ
Common questions about Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. is scheduled to report earnings for Q1 2026 on May 14, 2026.
Phio Pharmaceuticals Corp. has approximately 9 employees.